It was found that bromocoumarinplatin 1 could also activate p53 protein to enhance the anticancer activity and overcome the resistance of cisplatin through the p53 pathway.179 Diplatin, a novel platinum complex, had shown that the antitumor activity of diplatin against lung cancer cell lines was superior to that of carboplatin. Here, TP53 is linked to lung cancer.